Naveen Pemmaraju: Co-chairing the inaugural International Workshop on MPN24 meeting
Naveen Pemmaraju shared on LinkedIn:
“I recently had the opportunity to co-chair with Prof Claire Harrison the MPN day of the inaugural International Workshop on MPN24 meeting as part of the 2nd International Workshop on MDS-MPN meeting in Boston. I was able to deliver invited talks on both BCLxLi in MPNs and BPDCN overview.
Thanks to Amer Zeidan and Charlie Grieve and Video Journal of Hematology and Hematological Oncology (VJHemOnc) team for hosting and inviting us! Wonderful to be joined by friends and colleagues.”
Source: Naveen Pemmaraju/LinkedIn
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
